Sun Pharmaceutical Industries (NSE: SUNPHARMA) is still technically strong after the recent breakout to new 52-week highs near ₹1,917, but short-term profit booking has started after Q4 results.
Current Trend
Medium-term trend: Bullish
Short-term trend: Range-bound to mildly corrective
Momentum remains positive above ₹1,800 zone.
Source pivot levels show resistance around ₹1,904 / ₹1,918 and support near ₹1,873 / ₹1,855.
Trading View
Above ₹1,905 → momentum can extend toward ₹1,950–1,990.
Closing below ₹1,840 → weakness may increase toward ₹1,780.
Ideal buy-on-dips zone: ₹1,840–1,865.
Positional stop loss: ₹1,790.
Current Trend
Medium-term trend: Bullish
Short-term trend: Range-bound to mildly corrective
Momentum remains positive above ₹1,800 zone.
Source pivot levels show resistance around ₹1,904 / ₹1,918 and support near ₹1,873 / ₹1,855.
Trading View
Above ₹1,905 → momentum can extend toward ₹1,950–1,990.
Closing below ₹1,840 → weakness may increase toward ₹1,780.
Ideal buy-on-dips zone: ₹1,840–1,865.
Positional stop loss: ₹1,790.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.